Research Article

High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma

Figure 3

Overall survival (OS) in patients stratified by prognostic factors found to be independently associated with OS. (a) predicts poor prognosis in patients with resectable pancreatic ductal adenocarcinoma. . (b) Poor differentiation predicts poor prognosis in patients with resectable pancreatic ductal adenocarcinoma. . (c) High expression of JAK2 predicts poor prognosis in patients with resectable pancreatic ductal adenocarcinoma. . Significant differences in OS were revealed by the log-rank test.
(a)
(b)
(c)